濮阳东方医院看男科病非常可靠濮阳东方妇科医院做人流手术非常专业,濮阳东方医院看早泄怎么样,濮阳东方妇科看病不贵,濮阳东方医院割包皮很便宜,濮阳东方男科医院看病不贵,濮阳东方医院男科治阳痿价格收费低,濮阳东方医院看男科病评价很不错

SAN FRANCISCO, June 13 (Xinhua) -- Google on Monday confirmed that it had signed an agreement to buy Admeld, an on-line advertising optimization firm, in a deal seen as the Internet search giant's latest move to bolster its on-line display ad business.Admeld, launched in 2007 and headquartered in New York City, has developed a service that can help on-line publishers manage their ad space more efficiently and profitably.Admeld now has more than 500 customers worldwide, among them are FOX News, IDG TechNetwork, Discovery and The Weather Channel, according to information posted on its website."By combining Admeld's services, expertise and technology with Google's offerings, we're investing in what we hope will be an improved era of flexible ad management tools for major publishers, " Neal Mohan, Google's vice president of display advertising, said in a blog post announcing the deal."We believe that this investment will be an important step to help on-line publishers, and will further improve and grow the display advertising industry as a whole," Mohan noted.On-line display ads usually appear in forms that consist of images and may be interactive. According to the Interactive Advertising Bureau, a U.S. trade association, display-related on- line ad revenue in the United States totaled nearly 10 billion U.S. dollars in 2010.Financial terms of the deal were not disclosed by the two companies. TechCrunch, a technology blog site, has reported that Google paid around 400 million dollars.

CAIRO, July 4 (Xinhua) -- U.S. and Italian archeologists have discovered the oldest description about an Egyptian king (about 3, 200 BC) in Egypt's Aswan, Egyptian Antiquities Minister Zahi Hawass said on Monday.The engravings "traces back to when the Egyptian language firstly recorded in hieroglyphs and tells about a unique complete royal ceremony which was known in the ancient Egyptian era," said Hawass in a statement."The pharaoh appears to be wearing the Upper Egypt crown accompanied by (Horus apostles) at the royal court, " Hawass added.Horus is one of the oldest and most significant deities in the ancient Egyptian religion and was worshipped from at least the late Predynastic period through to Greco-Roman times."This discovery is considered a supplementary one at the site unearthed near in el-Hamdulab site in northern Aswan, archaeologists said.This is one of the latest discoveries in Egypt as the surrounding wall of Betah temple (1550 BC-1070 BC) and a gate traces back to Shabaka king era were unearthed on Saturday in Luxor.

LOS ANGELES, June 10 (Xinhua) -- The Aquarius/SAC-D observatory, NASA's first ever satellite to study the saltiness of Earth's oceans, is in excellent health after its launch early Friday, initial telemetry reports showed.The observatory rocketed into space from Vandenberg Air Force Base in California atop a United Launch Alliance Delta II rocket at 7:20:13 a.m. PDT (10:20:13 a.m. EDT).Less than 57 minutes later, the observatory separated from the rocket's second stage and began activation procedures, establishing communications with ground controllers and unfurling its solar arrays, NASA's Jet Propulsion Laboratory (JPL) said.During the next 25 days, the Aquarius/SAC-D service platform will be tested and maneuvered into its final operational, near-polar orbit 408 miles (657 kilometers) above Earth. Science operations will begin after the observatory's instruments are checked out. This commissioning phase may last up to 65 days, JPL said.Aquarius will map the global open ocean once every seven days for at least three years with a resolution of 93 miles (150 kilometers). The maps will show how ocean surface salinity changes each month, season and year. Scientists expect to release preliminary salinity maps later this year."Aquarius is a critical component of our Earth sciences work, and part of the next generation of space-based instruments that will take our knowledge of our home planet to new heights," said NASA Deputy Administrator Lori Garver. "The innovative scientists and engineers who contributed to this mission are part of the talented team that will help America win the future and make a positive impact across the globe."Aquarius will measure salinity by sensing thermal microwave emissions from the water's surface with three microwave instruments called radiometers. When other environmental factors are equal, these emissions indicate the saltiness of surface water. A microwave radar scatterometer instrument will measure ocean waves that affect the precision of the salinity measurement.Because salinity levels in the open ocean vary by only about five parts per thousand, Aquarius will be able to detect changes as small as approximately two parts per 10,000, equivalent to about one-eighth of a teaspoon of salt in a gallon of water."Data from this mission will advance our understanding of the ocean and prediction of the global water cycle," said Michael Freilich, director of NASA's Earth Science Division in the Science Mission Directorate at agency headquarters in Washington. "This mission demonstrates the power of international collaboration and accurate spaceborne measurements for science and societal benefit. This would not be possible without the sustained cooperation of NASA, CONAE and our other partners."The Aquarius/SAC-D (Satellite de Aplicaciones Cientificas) observatory is a collaboration between NASA and Argentina's space agency, Comision Nacional de Actividades Espaciales (CONAE).Aquarius was built by NASA's JPL and the Goddard Space Flight Center in Greenbelt, Maryland. NASA's Launch Services Program at the Kennedy Space Center in Florida manages the launch.JPL will manage Aquarius through its commissioning phase and archive mission data. Goddard will manage Aquarius mission operations and process science data. CONAE is providing the SAC-D spacecraft, optical camera, thermal camera with Canada, microwave radiometer, sensors from various Argentine institutions and the mission operations center. France and Italy also are contributing instruments.

THE HAGUE, Aug. 16 (Xinhua) -- ESBL-enzymes, which are known for their ability to stop the effects of antibiotics, can directly pass from chicken to people, said a research published on Tuesday.Veterinary researcher Dik Mevius of the Wageningen University released the finding in the magazine Resource.The research group led by Mevius has isolated six ESBL-genes varieties and compared them to bacteria found on hospital patients, on super market poultry and in laying batteries. In 35 percent of all cases, they discovered a match of 100 percent.Bacteria like Klebsiella on E. coli can produce the ESBL-enzymes. A healthy person will not feel any effect, but people with a lower immune system can get very sick. In areas like a hospital, the infection can easily spread."The main concern is that the enzyme resists the most used antibiotics, which makes the treatment of infected persons difficult," said Mevius.According to Mevius, 94 percent of supermarket poultry carries the enzyme, but all enzymes will be killed during the heating process of cooking.

BEIJING, August 4 (Xinhuanet) -- Medtronic Inc. is giving Yale University a 2.5 million U.S. dollar grant to review the safety and effectiveness of its controversial spine treatment called Infuse Bone Graft, according to The Wall Street Journals Thursday.Under terms of the pact, the company will release to Yale and eventually the public what participants described as an unprecedented amount of clinical trial and other data. The university will select two research teams from other organizations to perform separate analyses of the data.The announcement comes in the wake of a paper in June in the Spine Journal. The paper revealed that several clinical studies of Infuse, conducted by surgeons with strong economic ties to Medtronic, failed to report serious complications that arose in the trials. The critical paper also found that many of the studies were designed in ways in favor of Infuse over a treatment given to a control group.Medtronic disputes some of the findings and is conducting an internal investigation of the matter.Infuse accounts for about 700 million dollars in annual sales for Medtronic. The product is under investigation by the Senate Finance Committee over the role payments to physicians who may have played how studies were reported.